Corbus Pharmaceuticals Holdings, Inc. Share Price & Technical Analysis
CRBP · $11.35 (-1.39%)
Healthcare / Biotechnology
$11.35
-1.39%
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatm…
Price chart
Seasonality
May has 3 positive and 1 negative years (last 5 years shown)
15% return in May, 8% avg return in past 3 year May month.
36% return in 2026, 155% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | 1% | 5% | 11% | 4% | 15% | – | – | – | – | – | – | – | 36% |
| 25 | -18% | -20% | -30% | 42% | 0% | -8% | 35% | 3% | 35% | -5% | -6% | -29% | -1% |
| 24 | 342% | 19% | 27% | -6% | 16% | 0% | 33% | 3% | -66% | -22% | 11% | -37% | 320% |
| 23 | 34% | -37% | 143% | 22% | 8% | -18% | -8% | 1% | -8% | -17% | 34% | -8% | 147% |
| 22 | -28% | -25% | 54% | -37% | -11% | -16% | -8% | -23% | -18% | -28% | 45% | -27% | -121% |
Monthly return % by calendar month · historical pattern, not a forecast
Bearish · Downtrend · Weak
Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$195.10M
P/E ratio
—
52W high
$20.56
52W low
$6.72
Volume
5,55,213
Beta
2.68
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Corbus Pharmaceuticals Holdings, Inc. share price today?
- Corbus Pharmaceuticals Holdings, Inc. (CRBP) last traded around $11.35 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does CRBP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for CRBP. Download the app for real-time alerts.
- How can I analyze Corbus Pharmaceuticals Holdings, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.